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Abstract
Background:  Animal studies investigating the beneficial effects of Puerariae radix on
cardiovascular disease have suggested this plant possesses anti-diabetic and lipid lowering
properties. However, the exact mechanism by which Puerariae radix affects lipid metabolism is
currently unknown. The aim of this study was to investigate the effect of the water extract of
Puerariae radix on the secretion of VLDL and chylomicrons from HepG2 liver cells and CaCo2
cells, respectively, in humans.
Methods: The amount of apoB100 (a protein marker for VLDL) and apoB48 (a protein marker
for chylomicrons) in cells and media were quantified by Western Blotting and enhanced
chemiluminescence (ECL). Total, free and esterified cholesterol concentrations were measured by
gas liquid chromatography.
Results: Treatment of cells with water extract of Puerariae radix significantly decreased apoB100
production and secretion from HepG2 cells up to 66% in a dose dependent manner. The
intracellular total cholesterol and free cholesterol concentration in HepG2 cells also decreased
with increasing concentration of the Puerariae radix. In contrast, water extract of Puerariae radix
attenuated apoB48 concentrations in cells, but not apoB48 secretion from CaCo2 enterocytes.
Conclusions:  Collectively, our findings suggest that the water extract of Puerariae radix
attenuates the hepatic lipoprotein production and secretion. Our present cell culture findings may
explain why circulating VLDL and LDL levels were attenuated in animals supplemented with
Puerariae radix. Since decreasing the production and secretion of atherogenic lipoproteins
decreases the risk of development of cardiovascular disease, diets supplemented with radix may
provide a safe and effective beneficial cardioprotective effects in humans.
Background
Central to the pathology of coronary heart disease is the
accumulation of cholesterol within the intima of arterial
blood vessels. There is considerable evidence implicating
low density lipoprotein (LDL) as a primary source of
plaque cholesterol. There is now an accumulating body of
evidence which suggests that remnants of postprandial li-
poproteins, such as chylomicrons, may be atherogenic
when their concentrations in plasma is chronically elevat-
ed [1–3]. Apolipoprotein B48 (apoB48) is a structural
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protein moiety residing on the surface of chylomicrons,
and is necessary for the synthesis and secretion of this in-
testinal lipoprotein. Whereas, apolipoprotein B100
(apoB100) is exclusively synthesised by the liver and is the
principal constituent of very low density lipoprotein
(VLDL), the precursor of LDL [4]. In general, apoB con-
taining lipoproteins are associated with increased athero-
sclerotic risk. Current therapeutic interventions focus on
reducing the plasma concentration of LDL and chylomi-
cron remnants by decreasing their production and also by
promoting clearance from plasma by the hepatic LDL re-
ceptor [5]. Specific therapeutic strategies include im-
proved dietary habits, lifestyle changes, and/or powerful
lipid lowering drugs. In this study, we examined the ef-
fects of Puerariae radix, a putative hypolipidaemic agent,
on VLDL and chylomicron production from liver and in-
testinal cells.
Many epidemiological studies have shown that diet rich
in fruits and vegetables can protect against the develop-
ment of cardiovascular disease [6,7]. Researchers have ex-
amined the composition of these foods, and identified the
physiologically active components as phytochemicals
(non-nutritive substances in plants that possess health-
protective effects). Plant phytochemicals are categorised
into plant sterols, flavonoids, and plant sulfur com-
pounds. A large number of studies have demonstrated the
beneficial effects of flavonoid consumption against the
development of cancer and cardiovascular disease [6–8].
Pueraria Lobata is a traditional oriental medicinal plant
(also grown in the US) which is rich in flavonoids. The
root of this plant, Puerariae radix is especially rich in the
isoflavones (a class of flavonoids), such as daidzein, daid-
zin, puerarin, genistein and daidzein-4',7-diglucoside
[9,10]. Puerariae radix is widely used to cure alcoholism,
hypertension, common colds, influenza, menopause and
improve vascular activities [11–13]. The health-food in-
dustry is claiming that Puerariae radix is a health promot-
ing herb and advocating taking pure "radix" pills. There
appears to be many claims about the Puerariae radix with-
out strong scientific evidence supporting that it has bene-
ficial effects.
We have recently demonstrated that Puerariae radix has
potential anti-diabetic and lipid lowering properties in
animals [14]. Significant lipid lowering effects were ob-
served in rats when they were supplemented with Puerar-
iae radix (water extract) in association with a high fat-high
cholesterol diet compared to control rats [14]. VLDL and
LDL cholesterol levels were significantly decreased in rats
fed the water extract of Puerariae radix. However, the exact
mechanism by which Puerariae radix affects lipid metab-
olism is currently unknown. The aim of this study was to
investigate whether Kudzu decreases the production of
hepatic and intestinal lipoproteins in humans. HepG2 liv-
er cells and CaCo2 intestinal enterocytes represent two
cell culture model systems which show morphological
and biochemical properties consistent with hepatic cells
and fully differentiated small intestinal enterocytes, re-
spectively. In this study, cells were incubated with the wa-
ter extract of Kudzu and the secretion of apoB100 (a
protein marker for VLDL) from HepG2 liver cells and
apoB48 (a protein marker for chylomicrons) from Caco2
cells was quantified.
Methods
The human transformed colonic epithelial CaCo2 cells
and HepG2 cells were purchased from ATCC (American
Type Culture Collection). Cell culture media, reagents and
fetal bovine serum (certified grade) were from Gibco BRL
Life Technologies, Gaithsburg, MD, USA. Costar tran-
swell, polycarbonate microporous cell culture inserts and
flasks for tissue culture were obtained from Corning,
Cambridge, MA. Bis-(trimethylsilyl)-trifluoroacetimide
(BSTFA) and bicinchoninic acid (BCA) protein assay rea-
gents were obtained from Pierce, Rockford, Illinois. Benz-
amidine, PMSF, 25-hydroxycholesterol, 5α-cholestane,
Triton X-100 and other common laboratory reagents were
from Sigma Chemical Co, St. Louise, USA. Polyvinylidene
fluoride (PVDF) membrane was from Millipore Corpora-
tion, Bedford MA. Ultrapure electrophoresis reagents were
from Bio-Rad Laboratories, Richmond, USA. Enhanced
chemiluminescence detection reagents, hyper-film ECL,
and rabbit anti-donkey IgG, were purchased from Amer-
sham International, England. Rabbit anti-human apoB
antibody was purchased from DAKO A/S Denmark.
Preparation of Water extract of Puerariae radix
Puerariae radix (100 g) was dried, chopped and extracted
in 500 ml of boiling water for 4 h. After filteration, the ex-
tract was concentrated with a vacuum rotary evaporator
and freeze-dried. Water extract solutions was prepared
freshly prepared daily by adding the required grams of the
freezed dried extract of Puerariae radix in 100 ml hot wa-
ter to make a mg/ml solution.
HepG2 cell culture
Human cell line HepG2 cells were grown under 5% CO2
at 37°C in Dulbecco's modified Eagle's media (DMEM)
containing 10% (v/v) fetal calf serum (v/v) and 1% peni-
cillin-streptomycin-glutamine [15]. Cells were grown in
175 cm2  flasks containing DMEM supplemented with
10% FCS until confluent. Cells were then subcultured at 5
× 105 cells into 25 cm2 flasks containing the same media.
Cells were preincubated in serum free medium supple-
mented with 1% bovine serum albumin (BSA) then incu-
bated for 24 h in the various amounts (0–0.44 mg/ml) of
water extract of Puerariae radix.BMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/12
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CaCo2 cell culture
Human epithelial CaCo2 cells were grown at 37°C in
DMEM with 20% fetal calf serum (v/v), 2% penicillin-
streptomycin-glutamine and 1% non-essential amino ac-
ids. Cells were seeded at a density of 1 × 106 in 75 cm2
flasks [16]. The media was replaced every 2 days. Cells
were subcultured from flasks at 90% confluency, to poly-
carbonate microporous membranes (0.4 um pore size, in-
serts of 24.5 mm diameter) and plated at a density of 2 ×
104  cells/6.5 mm diameter filter. Fully differentiated
CaCo2 cells were used for all experiments (13 days post-
subculturing). Cells were incubated for 24 h in different
amount of water extract of Puerariae radix and DMEM
supplemented with 2% penicillin-streptomycin-
glutamine and 1% non-essential amino acids. 'Treatment'
media was added to the apical well after washing the cells
with phosphate buffered saline (PBS).
Cell isolation
HepG2 and CaCo2 cells were washed, harvested and re-
suspended in PBS following the 24 h incubation period
with the 'treatment' media. An aliquot of cells was used to
determine free and total cholesterol by Gas liquid Chro-
matography (GLC) [15] and another small aliquot was
used to measure cell protein using an enhanced bicin-
choninic acid procedure [15]. The remaining cells were
solubilised in buffer (3% Triton X-100 in PBS with 1 mM
benzamidine, and 1 mM PMSF) at 4°C for 18 h. Samples
were pelleted at 400 × g for 5 min at 4°C, the supernatant
collected and the cell debris discarded. The supernatant
was used to measure apoB100 and apoB48 by Western
blot and enhanced chemiluminscence (ECL) [15,16]. A
small aliquot of the supernatant was used to measure sol-
ubilised protein.
The media from HepG2 cells and the basolateral well
from CaCo2 cells was measured and kept on ice. Aliquots
of media was used to measure apoB100and apo B48 by
Western blots and ECL.
Sterol quantitation
Lipid was extracted from solubilised CaCo-2 and HepG2
cells for the analysis of free cholesterol using a modified
method of Folch et al. [17]. Briefly, 1 ml of chloroform
(CHCl3) was added to cells along with internal standard
(5α-cholestane) and 25 µl of saturated salt solution to
prevent the formation of a fatty acid emulsion. Samples
were mixed thoroughly and centrifuged at 200 × g for 10
min. The top aqueous layer was aspirated and discarded
and the lower chloroform layer dried under a stream of
N2. Samples were reconstituted in hexane before GC anal-
ysis.
To measure total cholesterol in the cells, 1 ml of 1 M KOH
in methanol was added to an aliquot of cells to saponify
cholesterol esters. The tubes were then flushed with N2
and heated at 45°C for 1 h. After hydrolysis was complete,
the solution was diluted with 2 ml of water, internal
standard was added, and the lipids were extracted twice
with hexane (1 ml).
Free and total cholesterol were determined by comparison
of peak area with a five point external calibration curve.
An internal standard was used to correct for injection vol-
ume (1 uL) variability. Calibration was performed daily.
A Perkin Elmer Autosystem XL gas chromatograph fitted
with a ZB-1 dimethyl polysiloxane column (30 m × 530
µm, 1.5 µm film thickness, Phenomenex) and splitless in-
jector was used with helium as the carrier gas at a flow rate
of 6.0 mL/min. An estimate of esterified cholesterol was
derived as the difference between total and free cholester-
ol.
Apo B100 and Apo B48 Quantitation
Solubilised cell protein (100 µg), rainbow molecular
weight-markers and purified apo B100 and apo B48
standards (previously prepared according to Zilversmit
and Shea [18] were separated by SDS-PAGE using precast
NuPAGE 3–8% gradient gels in a Novex Mini-Cell (Novex
Instruments, CA, USA) at 150 V for 1 h. Separated pro-
teins were electrotransferred at 30 V for 90 min onto 0.45
µm polyvinylidene fluoride (PVDF) membrane. The
membranes were blocked for 1 h at 25°C in TBST (10 mM
Tris-HCL buffer, pH 7.4, containing 154 mM NaCl) and
10% (w/v) skim milk powder. After washing in TBST, the
membranes were incubated with 5.0 µg/ml apoB anti-
body (DAKO apo B rabbit anti-human). The membranes
were incubated with 0.5 µg/ml donkey anti-rabbit IgG
linked to horseradish peroxidase in TBST and subsequent-
ly washed twice with TBST. Membranes were incubated
with enhanced chemiluminescence substrate solution for
detection of horseradish and exposed to hyper-film ECL.
Films were scanned to determine the intensity of the
apoB48 protein bands using a UMAX Vista S6E Flatbed
Scanner and the intensity of the apoB and was quantitied
using the computer program Scion Image (Scion Incorpo-
ration). Bands of interest were compared against purified
apoB protein standard of known mass. The mean intra-
and inter-assay coefficient of variance for apo B were each
less than 4%. Experiments were done in duplicate and re-
peated 3–4 times on separate occasions.
Statistical Analysis
Statistical analysis was carried out using SPSS for version
10.0.7 (SPSS Incorp). Means were compared using one-
way analysis of variance (ANOVA) followed by Tukey's
post-hoc test. All means were compared to each other,
means with different letters above bar graphs indicate sig-
nificant differences at p < 0.05.BMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/12
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Results
The effect of water extract of Puerariae radix on apoB100 
production and secretion from HepG2 cells
The effect of water extract of Puerariae radix on apoB100
production in HepG2 cells was investigated. Cells were in-
cubated with 0–0.44 mg/ml water extract of Puerariae ra-
dix for 24 hours, and the apoB100 content in cells, as well
as the amount of apoB100 secreted into culture medium,
were determined. Figure 1 shows that cells incubated with
0.44 mg/ml water extract of Puerariae radix resulted in up
to a 62 % decrease in apoB100 levels in HepG2 cells com-
pared to control cells. Similarly, secretion of apoB100
from cells significantly decreased when incubated with
the water extract of Puerariae radix. Apolipoprotein B100
concentrations in the media decreased up to 66.2% when
incubated with 0.44 mg/ml of the extract. Cell viability
was determined using the Trypan Blue exclusion test.
There was no difference in cell viability between control
cells and cells treated with water extract of Puerariae radix
(data not shown).
The effect of water extract of Puerariae radix on choles-
terol content in HepG2 cells
The effect of water extract of Puerariae radix on cholesterol
metabolism in HepG2 cells was determined by GLC anal-
ysis. Treatment of the cells with water extract of Puerariae
radix significantly decreased the intracellular total and
free cholesterol levels (Fig 2). The free and total cholester-
ol content were lowest in cells when incubated with con-
centrations greater than 0.22 mg/ml of Puerariae radix
extract. Incubation of cells with Puerariae radix also de-
creased the intracellular concentration of cholesterol es-
ter, but this effect was only significant at the highest dose
of 0.44 mg/ml.
The effect of water extract of Puerariae radix on Apolipo-
protein B48 production and secretion in CaCo2 cells
Cells were incubated with 0–0.44 mg/ml Puerariae radix
water extract for 24 h, and the apoB48 content in these
cells and in culture medium was determined. The apoB48
concentration in the cells was significantly decreased by
25% when incubated with 0.33 mg/ml and 0.44 mg/ml of
water extract of Puerariae radix compared with control
cells (Figure 3). However, there was no significant differ-
ence on apoB48 levels in the media incubated with the
water extract.
The effect of water extract of Puerariae radix on choles-
terol content in CaCo2 cells
The effect of water extract of Puerariae radix on cholesterol
content in CaCo2 cells was determined using GLC. Total
cholesterol and esterified cholesterol in the cells signifi-
cantly decreased with water extract of Puerariae radix con-
centrations of greater than 0.22 mg/ml compared to
Figure 1
The effect of Puerariae radix water extract on Apo 
B100 production and secretion in HepG2 cells. HepG2 
cells were incubated with water extraction on Puerariae 
radix for 24 h. ApoB100 concentration in the cells and media 
were quantified and expressed as a percentage of control ± 
SEM (n = 4). Means were compared using one-way analysis of 
variance (ANOVA) followed by Tukey's post-hoc test. Dif-
ferent letters above bar graphs indicate significance from 
each other at p < 0.05.
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Figure 2
The effect of water extract of Puerariae radix on 
intracellular total, free and esterified cholesterol 
concentrations in HepG2 cells. Hep G2 cells were incu-
bated with water extract of Puerariae radix for 24 h. Total, 
free and esterified cholesterol levels were quantified by GLC 
and expressed as a percentage of control ± SEM (n = 3). 
Means were compared using one-way analysis of variance 
(ANOVA) followed by Tukey's post-hoc test. Different let-
ters in graphs indicate significance from each other at p < 
0.05. NS: not significant at p > 0.05
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control cells (Fig 4). There was no significant difference in
the concentration of free cholesterol within the cells incu-
bated with Kudzu at any concentration.
Discussion
Previous studies have demonstrated that circulating VLDL
and LDL cholesterol levels significantly decreased in rats
consuming a high fat diet supplemented with 5% Puerar-
iae radix of water extract [14]. These results suggest that
Puerariae radix (Kudzu) either attenuates the production
and secretion of these lipoproteins or that it increases
their clearance from circulation. To explore the former, we
examined the effect of the water extract of Puerariae radix
on secretion of apoB100 from HepG2 liver cells and
apoB48 from CaCo2 cells. Treatment of HepG2 cells with
increasing concentrations of Kudzu water extract signifi-
cantly decreased the amount of apoB100 in the cells and
media. Concomitantly, total and free cholesterol levels in
the cells also significantly decreased. Water extract of
Puerariae radix also decreased the intracellular concentra-
tion of esterified cholesterol but this effect was only signif-
icant at higher doses of 0.44 mg/ml. Our findings in cell
culture suggest that Kudzu may potentially attenuate the
circulating levels LDL in animals by regulating the secre-
tion of the precursor lipoprotein, VLDL. The decrease in
intracellular cholesterol metabolism may be the mecha-
nism by which VLDL secretion is decreased in liver cells.
Our results suggest that decreased cholesterol availability
in the presence of Kudzu may decrease the secretion of
apoB100 from hepatocytes. ApoB100 is mainly synthe-
sized and secreted by hepatocytes as VLDL before it is con-
verted to LDL in circulation [4]. The formation of hepatic
apoB100 containing lipoprotein particles is a complex
process that requires the coordinate synthesis and assem-
bly of apoB100, triglyceride (TG), cholesterol esters (CE),
phospholipids and other components [4]. It is believed
that apoB100 secretion is primarily regulated post-transla-
tionally as apoB100 production rates are directly correlat-
ed to the fraction of newly synthesised apoB100 that
escapes intracellular degradation during translocation
across the ER [4]. It is the availability of lipid which seems
to influence the proportion of newly synthesised apoB100
that is degraded [19,20]. However, it is unclear whether
the regulation exclusively involves triglyceride, cholester-
ol, cholesterol ester, phospholipids or, a combination of
these. Many in vitro [21–23] and in vivo [24,25] studies
have reported the importance of cholesterol and choles-
terol ester in the control of apoB100. Cell cultures studies
have shown that if cholesterol availability is limited by in-
troducing an HMG-CoA inhibitor (the rate limiting en-
zyme in cholesterol synthesis), then apoB100 secretion
will also be attenuated [25,26]. For example, we have
demonstrated that atorvastatin (an HMG-CoA inhibitor)
decreased apoB100 production and secretion from liver
Figure 3
The effect of Puerariae radix water extract on 
apoB48 production and secretion in CaCo2 cells. 
CaCo2 cells were incubated with water extract of Puerariae 
radix for 24. ApoB48 concentration in the cells and media 
were quantified and expressed as a percentage of control ± 
SEM (n = 3). Means were compared using one-way analysis of 
variance (ANOVA) followed by Tukey's post-hoc test. Dif-
ferent letters above bar graphs indicate significance from 
each other at p < 0.05. NS: Not significant at p > 0.05.
Figure 4
The effect of water extract of Puerariae radix on 
intracellular total cholesterol, free cholesterol and 
esterified cholesterol concentrations. CaCo2 cells 
were incubated with water extract of Puerariae radix for 24 
h. Total, free and esterified cholesterol levels in the cells are 
expressed as a percentage of control ± SEM (n = 3). Means 
were compared using one-way analysis of variance (ANOVA) 
followed by Tukey's post-hoc test. Different letters in graphs 
indicate significance at p < 0.05. NS: not significant at p > 0.05
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cells by inhibiting cholesterol biogenesis [27]. In addi-
tion, we have also recently demonstrated that green tea
catechins [28], and red wine polyphenolics [28] attenuat-
ed apoB100 production and secretion from liver cells by
inhibiting the cholesterol biosynthesis pathway in a simi-
lar manner to atorvastatin. Our findings herein also dem-
onstrate that Kudzu water extract significantly suppressed
intracellular cholesterol production (Figure 2), suggesting
that this compound(s) may act in a similar manner to
HMG-CoA reductase inhibitors to attenuate the secretion
of apoB100 from liver cells.
In contrast to the results observed in HepG2 cells, apoB48
was not significantly decreased from CaCo2 cells when in-
cubated with increasing concentrations of the Kudzu wa-
ter extract. Treatment of cells with water extract of
Puerariae radix significantly decreased the intracellular to-
tal cholesterol concentration with increasing concentra-
tions of the extract, but did not affect free cholesterol
levels in the cells. Water extract of Puerariae radix also de-
creased the intracellular concentration of esterified cho-
lesterol, but this effect was only significant at doses greater
than 1%. The reason why Puerariae radix affected apoB48
production, not affected apoB48 secretion is unknown.
However, we have previously shown that suppression of
cholesterol biosynthesis with atorvastatin (an HMG-CoA
reductase inhibitor) under stimulatory conditions acceler-
ated the degradation of apoB48 in CaCo2 cells without af-
fecting its secretion [16].
In humans, apoB48 is associated with chylomicrons and
chylomicron remnants, and is synthesised by the intestine
[29]. After ingesting a fat meal, the dietary lipids (triglyc-
eride and cholesterol) are packaged together with apoB48
into a chylomicron particle by the enterocyte [29]. Al-
though, the same regulatory mechanisms have been spec-
ulated to be responsible for both forms of apoB, there is a
body of evidence that suggests intestinal apoB48 control
differs to that of hepatic apoB100. Studies by Paulweber
at al [30] have shown that there are distinct differences be-
tween the promoter region of apoB genes of hepatic and
intestinal cells. Pau et al [31] reported that treatment with
CaCo2 cells with lovastatin had no effect on total apoB48
secretion under basal conditions. Consistent with these
findings, our previous studies showed that atorvastatin
did affect apoB48 secretion from CaCo2 cells [16]. In
these studies, the addition of exogenous sterols did not
stimulate apoB48 secretion from intestinal cells. In con-
trast, studies in liver cells all demonstrate the importance
of endogenous cholesterol synthesis (using HMG-CoA re-
ductase inhibitors) on apoB100 secretion in hepatocytes.
Taken together, studies indicate that neither endogenous
nor exogenous cholesterol appears to acutely modulate
apoB48 secretion from intestinal cells, but does regulate
apoB100 secretion from liver cells. Similarly, the effect of
Kudzu on apoB100 secretion from liver cells maybe deter-
mined by cholesterol availability, but not in intestinal
cells.
Puerariae radix contains high levels of the phytoestrogens
(plant-derived substances with weak estrogenic effects),
daidzin, daidzein and puerarin, along with other related
isoflavones [9,10,12,32,33]. These constituents are the ba-
sis of Kudzu's therapeutic use for menopause by the Ori-
entals, consuming the crushed root (9–15 grams/ day)
prepared as tea [12,33,34]. Soy is also an excellent dietary
source of these phytoestrogens and thus consumed by
many western women to alleviate the many adverse effects
of menopause (hot flashes, increases in lipids, blood sug-
ar). Presently, the health-food industry is claiming that
the compounds in Puerariae radix decrease symptoms of
menopausal and blood lipids, and are therefore promot-
ing the consumption of pills containing several grams of
pure Puerariae radix. At present, strong scientific evidence
supporting that Kudzu provides such beneficial effects is
limited. In this study, we have demonstrated that Puararia
radix can decrease lipoprotein production and secretion
from the liver cells by affecting cholesterol availability
within the cell, similar to lipid lowering drugs. Our
present cell culture findings may explain why circulating
VLDL and LDL levels were attenuated in animals supple-
mented with Kudzu [14]. It has been approved that disor-
ders of lipid metabolism result in an increased risk for
atherosclerosis and that lowering of LDL-cholesterol and
postprandial lipoproteins reduces morbidity and mortali-
ty from CHD [5]. Since decreasing the production and se-
cretion of atherogenic lipoproteins decreases the risk of
development of cardiovascular disease, diets supplement-
ed with Kudzu may provide an effective beneficial cardio-
protective effects in humans. However, further studies in
humans are required to examine the bioavailability and
the doses of Puerariae radix required to have significant li-
pid lowering before recommendations can be made.
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